Format

Send to

Choose Destination
J Am Acad Dermatol. 2019 Jul;81(1):e9-e10. doi: 10.1016/j.jaad.2019.02.012. Epub 2019 Feb 13.

Utilization of optical coherence tomography as a noninvasive, bedside imaging technique to identify residual nodular basal cell carcinoma at a well-healed and clinically unidentifiable biopsy site.

Author information

1
Laser and Skin Surgery Center of New York, New York, New York; The Ronald O. Perelman Department of Dermatology, New York University, New York, New York. Electronic address: haofeng625@gmail.com.
2
Laser and Skin Surgery Center of New York, New York, New York; The Ronald O. Perelman Department of Dermatology, New York University, New York, New York.
3
Michelson Diagnostics Ltd, Maidstone, United Kingdom.

KEYWORDS:

OCT; bedside imaging; biopsy site identification; dermatologic surgery; optical coherence tomography; skin cancer; wrong site surgery

PMID:
30771419
DOI:
10.1016/j.jaad.2019.02.012
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center